Researchers, WEDNESDAY, November 14, 2018 (HealthDay News) – Obesity can increase the risk of developing fatal pancreatic cancer in adulthood.
The Israeli research team suggests that the possibility of this rare cancer can be quadrupled depending on obesity. Moreover, the risk increases as the weight increases, even when affecting men in the high normal weight range.
It has been known for some time that obesity may increase the risk of developing an individual's pancreatic cancer. [this is] Allison Rosenzweig, a senior executive of the Pancreatic Cancer Action Network, is an important new finding showing that obesity and overweight can also affect risk during adolescence.
But being overweight or obese cannot prevent the disease from being caught, because Rosenzweig has no role in the study.
”Since pancreatic cancer is a relatively rare disease, considering that it affects about 55,000 Americans this year, even those at increased risk are less likely to develop the disease,“ he said.
Moreover, since this study looks at retrospective data, it cannot prove that there is only one relationship between overweight and pancreatic cancer.
According to the cancer network, pancreatic cancer is the third leading cause of cancer deaths in the US with a five-year survival rate below 10 percent.
For the new study, Petah Tikva and Dr. Rabin Medical Center at Tel Aviv University. Researchers led by Zohar Levi gathered information about more than 1 million Jewish men and 700,000 Jewish women in Israel. Participants had physical examinations between 16 and 19 years of age from 1967 to 2002.
Using the Israeli National Cancer Registry, researchers have identified cases of pancreatic cancer by 2012. There were 551 new cases of pancreatic cancer.
According to normal weight, obesity was about four times higher risk for cancer among men. The risk among women among researchers was slightly more than four times.
In general, researchers attributed almost 11 percent of pancreatic cases to overweight and obesity.
The report was published online in the journal on November 12 Cancer.